Evidence map›Paper›PMID 39087478›Full record

ArticleThe Journal of clinical investigation2024

Convergent generation of atypical prions in knockin mouse models of genetic prion disease.

Surabhi Mehra, Matthew Ec Bourkas, Lech Kaczmarczyk, Erica Stuart, Hamza Arshad, Jennifer K Griffin, Kathy L Frost, Daniel J Walsh, Surachai Supattapone, Stephanie A Booth and 2 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Enhanced lysosomal activity prevents infection with PrPThe Journal of biological chemistry · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Surabhi MehraTanz Centre for Research in Neurodegenerative Diseases and.
Matthew Ec BourkasTanz Centre for Research in Neurodegenerative Diseases and.
Lech KaczmarczykWallenberg Center for Molecular Medicine, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Erica StuartTanz Centre for Research in Neurodegenerative Diseases and.
Hamza ArshadTanz Centre for Research in Neurodegenerative Diseases and.
Jennifer K GriffinTanz Centre for Research in Neurodegenerative Diseases and.
Kathy L FrostOne Health Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Daniel J WalshDepartment of Biochemistry and Cell Biology and.
Surachai SupattaponeDepartment of Biochemistry and Cell Biology and.
Stephanie A BoothOne Health Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Walker S JacksonWallenberg Center for Molecular Medicine, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Joel C WattsTanz Centre for Research in Neurodegenerative Diseases and.

Funding

Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MADDEN, DEAN R · 2016 to 2025
$25.9M
Mapping Molecular Pathways that Control Prion MetabolismR37NS125431 · NINDS · DARTMOUTH COLLEGE · PI Surachai Supattapone · 2022 to 2026
$3.5M
Structural Mechanism of Mammalian Prion InfectivityR01NS118796 · NINDS · DARTMOUTH COLLEGE · PI SUPATTAPONE, SURACHAI, ZILM, KURT WILLIAM · 2020 to 2024
$2.8M
Novel Therapeutic Strategies Targeting Malleability of Wild-Type and Mutant PrionsR01NS117276 · NINDS · DARTMOUTH COLLEGE · PI SUPATTAPONE, SURACHAI · 2020 to 2025
$2.4M
NINDS NIH HHS R01 NS117276NINDS NIH HHS R01 NS118796NINDS NIH HHS R37 NS125431
6 · The paper itself

Abstract

Most cases of human prion disease arise due to spontaneous misfolding of WT or mutant prion protein, yet recapitulating this event in animal models has proven challenging. It remains unclear whether spontaneous prion generation can occur within the mouse lifespan in the absence of protein overexpression and how disease-causing mutations affect prion strain properties. To address these issues, we generated knockin mice that express the misfolding-prone bank vole prion protein (BVPrP). While mice expressing WT BVPrP (I109 variant) remained free from neurological disease, a subset of mice expressing BVPrP with mutations (D178N or E200K) causing genetic prion disease developed progressive neurological illness. Brains from spontaneously ill knockin mice contained prion disease-specific neuropathological changes as well as atypical protease-resistant BVPrP. Moreover, brain extracts from spontaneously ill D178N- or E200K-mutant BVPrP-knockin mice exhibited prion seeding activity and transmitted disease to mice expressing WT BVPrP. Surprisingly, the properties of the D178N- and E200K-mutant prions appeared identical before and after transmission, suggesting that both mutations guide the formation of a similar atypical prion strain. These findings imply that knockin mice expressing mutant BVPrP spontaneously develop a bona fide prion disease and that mutations causing prion diseases may share a uniform initial mechanism of action.

Indexed as

Disease Models, AnimalGene Knock-In TechniquesMice, TransgenicPrion DiseasesPrion ProteinsAmino Acid SubstitutionAnimalsArvicolinaeBrainHumansMiceMutation, MissensePrionsProtein FoldingPrion ProteinsPrionsNeurodegenerationNeurosciencePrions

Identifiers

PMID39087478
PMCPMC11291267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.